Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

NSE/SOTAC stock hub

NSE/SOTAC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SOTACis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SOTAC

In the news

Latest news · NSE/SOTAC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E13.7

P25 24.8P50 35.9P75 56.9

ROE18

P25 6.3P50 13.6P75 18.1

ROIC9.8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SOTAC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

INR

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	127
Employees Change	59%
Employees Change Percent	86.76
Enterprise value	INR 1.6B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	INE0O2D01012
Last refreshed	2026-05-10
Market cap	INR 1.2B
Price	INR 106
Price currency	INR
Rev Per Employee	6,667,086.61x
Sector	Healthcare
Sic	2834
Symbol	nse/SOTAC
Website	https://sotacpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.31%
EV Earnings	18.51x
EV/EBIT	14.11x
EV/EBITDA	9.74x
EV/FCF	-11.76x
EV/Sales	1.87x
FCF yield	-11.51%
P/B ratio	1.92x
P/E ratio	13.7x
P/S ratio	1.38x
PE Ratio3 Y	29.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.27%
EBITDA Margin	19.23%
Gross margin	39.68%
Gross Profit	INR 336M
Gross Profit Growth	48.85%
Gross Profit Growth Q	15.74%
Gross Profit Growth3 Y	52.62%
Net Income	INR 85.6M
Net Income Growth	91.93%
Net Income Growth Q	116.07%
Pretax Margin	14.11%
Profit Margin	10.11%
Profit Per Employee	INR 674,016
ROA	5.88
Roa5y	5.46
ROCE	15.92
ROE	18.04
Roe5y	8.53
ROIC	9.78
Roic5y	11.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-15.11%
Cagr3y	-2.65%
EPS Growth	91.77
EPS Growth Q	132.5
Revenue Growth	-19.27x
Revenue Growth Q	-32.33x
Revenue Growth3 Y	20.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.71
Assets	INR 1.2B
Cash	INR 22M
Current Assets	INR 705.5M
Current Liabilities	INR 527M
Debt	INR 382.4M
Debt EBITDA	INR 2.35
Debt Equity	INR 0.63
Debt FCF	INR -2.84
Equity	INR 609.9M
Interest Coverage	3.63
Liabilities	INR 622.7M
Long Term Assets	INR 527.2M
Long Term Liabilities	INR 95.7M
Net Cash	INR -360.4M
Net Cash By Market Cap	INR -30.77
Net Debt EBITDA	INR 2.21
Net Debt Equity	INR 0.59
Tangible Book Value	INR 537.6M
Tangible Book Value Per Share	INR 48.58
WACC	4.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.34
Inventory Turnover	2.86
Net Working Capital	INR 444.8M
Quick ratio	0.66
Working Capital	INR 178.5M
Working Capital Turnover	INR 6.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	INR 0.1
Dividend Years	1
Dividend Yield	0.09%
Last Dividend	INR 0.1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-15.1%
200-day SMA	121.3
3Y total return	-7.75%
50-day SMA	116
50-day SMA vs 200-day SMA	50under200
All Time High	202.8
All Time High Change	-47.73%
All Time High Date	2024-07-15
All Time Low	87.1
All Time Low Change	21.7%
All Time Low Date	2024-06-05
ATR	3.65
Beta	0
Beta1y	0.03
Beta2y	0.18
Ch YTD	-13.89
High	106
High52	152.4
High52 Date	2025-07-01
High52ch	-30.42%
Low	106
Low52	100
Low52 Date	2026-01-16
Low52ch	6%
Ma50ch	-8.61%
Price vs 200-day SMA	-12.64%
RSI	44.74
RSI Monthly	46.56
RSI Weekly	44.62
Sharpe ratio	0.15x
Sortino ratio	0.32
Total Return	0.05%
Tr YTD	-13.89
Tr1m	3.92%
Tr1w	-4.63%
Tr3m	-10.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 112.3M
Operating Income Growth	103.6
Operating Income Growth Q	-65.44
Operating margin	13.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,432,250%
Net Borrowing	102,552,000
Shares Insiders	68.94%
Shares Out	11,050,000
Shares Qo Q	0%
Shares Yo Y	0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -134.8M
Average Volume	13,020x
Bv Per Share	50.31
CAPEX	INR -102.9M
Ch1m	3.92
Ch1w	-4.63
Ch1y	-15.17
Ch3m	-10.4
Ch3y	-7.83
Ch6m	-17.83
Change	0%
Change From Open	0
Close	106
Days Gap	0
Depreciation Amortization	50,450,000
Dollar Volume	127,200
Earnings Date	2026-05-22
EBIT	INR 112.3M
EBITDA	INR 162.8M
EPS	INR 7.74
F Score	5
FCF	INR -134.8M
FCF EV Yield	-8.51x
FCF Per Share	INR -12.2
Financing CF	67,949,000
Fiscal Year End	March
Founded	2,014
Goodwill	19,034,000
Graham Number	93.59359
Graham Upside	-11.7
Income Tax	INR 18.5M
Investing CF	-19,274,000
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-09-30
Ma150	119.2
Ma150ch	-11.07%
Ma20	108
Ma20ch	-1.89%
Net CF	16,789,000
Next Earnings Date	2026-05-22
Open	106
Payment Date	2025-10-29
Ppne	462,200,000
Price Date	2026-05-08
Price EBITDA	INR 7.2
Ptbv Ratio	2.18
Relative Volume	0.09x
Revenue	846,720,000x
Tax By Revenue	2.19x
Tax Rate	15.52%
Tr6m	-17.83%
Volume	1,200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/SOTAC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.10 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+0.0%

Dividend yield + buyback yield combined

Performance

NSE/SOTAC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/SOTAC?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+68.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/SOTAC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

-12.6%

50/200-day relationship not available

Beta (5Y)

0.00

Less volatile than the market

Sharpe ratio

0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SOTAC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SOTAC stock rating?

nse/SOTAC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SOTAC analysis?

The full report lives at /stocks/nse/SOTAC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SOTAC?

The latest report frames nse/SOTAC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SOTAC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.